Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer

Endometrial cancer is the most common malignancy of the female genital tract and a major cause of morbidity and mortality in women. Early detection is key to ensuring good outcomes but a lack of minimally invasive screening tools is a significant barrier. Most endometrial cancers are obesity-driven...

Full description

Bibliographic Details
Main Authors: Kelechi Njoku, Amy E. Campbell, Bethany Geary, Michelle L. MacKintosh, Abigail E. Derbyshire, Sarah J. Kitson, Vanitha N. Sivalingam, Andrew Pierce, Anthony D. Whetton, Emma J. Crosbie
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
endometrial cancer
obesity
metabolomics
liquid biopsy
mass spectrometry
plasma biomarkers
Online Access:https://www.mdpi.com/2072-6694/13/4/718

Internet

https://www.mdpi.com/2072-6694/13/4/718

Similar Items